Moderna raises $450m; most ever for private biotech

Moderna Therapeutics raised $450m in what appears to be the largest-ever private equity event for a non-public biotechnology company, which will use the venture capital to develop therapies that deliver messenger RNA (mRNA) designed to produce proteins in the body.